Previous close | 37.45 |
Open | 37.41 |
Bid | 37.16 x 500 |
Ask | 37.28 x 200 |
Day's range | 36.91 - 37.72 |
52-week range | 15.44 - 40.21 |
Volume | |
Avg. volume | 1,486,380 |
Market cap | 6.184B |
Beta (5Y monthly) | 1.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Insights into RVMD's Financial Health and Future Directions
Revolution Medicines ( NASDAQ:RVMD ) First Quarter 2024 Results Key Financial Results Net loss: US$116.0m (loss widened...
Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript May 8, 2024 Revolution Medicines, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to Revolution Medicine’s First Quarter 2024 Earnings Conference […]